A detailed history of California State Teachers Retirement System transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 4,255 shares of TRVI stock, worth $17,275. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,255
Previous 4,255 -0.0%
Holding current value
$17,275
Previous $12,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.44 - $3.36 $43 - $60
18 Added 0.42%
4,255 $12,000
Q1 2024

May 15, 2024

SELL
$1.3 - $3.7 $3,511 - $9,993
-2,701 Reduced 38.93%
4,237 $14,000
Q4 2023

Feb 13, 2024

SELL
$1.06 - $2.05 $2,381 - $4,606
-2,247 Reduced 24.46%
6,938 $9,000
Q3 2023

Nov 14, 2023

SELL
$2.11 - $2.47 $9,838 - $11,517
-4,663 Reduced 33.67%
9,185 $20,000
Q2 2023

Aug 21, 2023

BUY
$1.8 - $3.44 $24,926 - $47,637
13,848 New
13,848 $33,000

Others Institutions Holding TRVI

About Trevi Therapeutics, Inc.


  • Ticker TRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,322,500
  • Market Cap $237M
  • Description
  • Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...
More about TRVI
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.